ask="7.20"
ask_size="700"
average_daily_volume="65998"
bid="4.80"
bid_size="400"
book_value="5.08"
change="+0.38"
change_from_200_day_moving_average="-0.45"
change_from_50_day_moving_average="0.56"
change_from_52_week_high="-7.57"
change_From_52_week_low="1.52"
change_in_percent="+7.92%"
close="5.18"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.06"
ebitda="-20.26M"
eps_estimate_current_year="-8.61"
eps_estimate_next_quarter="-0.80"
eps_estimate_next_year="-2.57"
ex_dividend_date="N/A"
float_shares="6404000"
high="5.23"
high_52_weeks="12.75"
last_trade_date="2/14/2017"
last_trade_price="5.18"
last_trade_size="226"
last_trade_time="4:00pm"
low="4.75"
low_52_weeks="3.66"
market_capitalization="69.57M"
moving_average_200_day="5.63"
moving_average_50_day="4.62"
name="Aeglea BioTherapeutics
Inc."
notes="N/A"
one_year_target_price="17.00"
open="4.94"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-8.00%"
percent_change_from_50_day_moving_average="+12.03%"
percent_change_from_52_week_high="-59.37%"
percent_change_from_52_week_low="+41.53%"
previous_close="4.80"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.95"
price_per_sales="12.98"
revenue="4.97M"
shares_outstanding="13430000"
short_ratio="2.04"
stock_exchange="NGM"
symbol="AGLE"
volume="340303"
weeks_range_52="3.66 - 12.75"
